Pharma Forecasting Launch

Philadelphia-based Wolters Kluwer Health has launched 'inThought™', a new MR service offering a range of pharmaceutical forecasting capabilities.

inThought aims to help financial analysts, health care suppliers and drug makers understand where developmental drugs, medical devices, and therapies are positioned today and predict their future direction. It promises to deliver data, analysis and forecasting from a single source, helping to streamline the market research process. The service integrates Wolters Kluwer Health's established clinical, prescription, managed markets, and patient information with the insight and forecasting abilities of a team of researchers, analysts and physicians.

'With research headcounts down, there's a fundamental shift in the way analysts and pharma customers want their research delivered', comments Ben Weintraub, inThought's Director of Research. 'Rather than simply striving to offer more data faster, our approach sifts through the clutter to synthesize what is truly important.'

The service has its own web site at www.in-thought.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.